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Abstract 
Reducing costs in terms of time, animal sacrifice, and material resources with computational methods has 
become a promising goal in Medicinal, Biological, Physical and Organic Chemistry. There are many 
computational techniques that can be used in this sense. In any case, almost all these methods focus on few 
fundamental aspects including: type (1) methods to quantify the molecular structure, type (2) methods to link 
the structure with the biological activity, and others. In particular, MARCH-INSIDE (MI), acronym for 
Markov Chain Invariants for Networks Simulation and Design, is a well-known method for QSAR analysis 
useful in step (1). In addition, the bio-inspired Artificial-Intelligence (AI) algorithms called Artificial Neural 
Networks (ANNs) are among the most powerful type (2) methods. We can combine MI with ANNs in order 
to seek QSAR models, a strategy which is called herein MIANN (MI & ANN models). One of the first 
applications of the MIANN strategy was in the development of new QSAR models for drug discovery. 
MIANN strategy has been expanded to the QSAR study of proteins, protein-drug interactions, and protein-
protein interaction networks. In this paper, we review for the first time many interesting aspects of the 
MIANN strategy including theoretical basis, implementation in web servers, and examples of applications in 
Medicinal and Biological chemistry. We also report new applications of the MIANN strategy in Medicinal 
chemistry and the first examples in Physical and Organic Chemistry, as well. In so doing, we developed new 
MIANN models for several self-assembly physicochemical properties of surfactants and large reaction 
networks in organic synthesis. In some of the new examples we also present experimental results which were 
not published up to date. 
Keywords: Artificial neural networks; Drug-target networks; Multitarget QSAR; Organic reaction networks; 
Protein interaction networks; Surfactant QSPR models  
 
 
 
 
 
 
  
1. INTRODUCTION  
Reducing costs in terms of time, animal sacrifice, and material resources with computational 
methods has become a promising goal in Medicinal, Biological, Physical and Organic Chemistry 
[1]. There are many computational techniques that can be used in this sense, to cite a few: 
Quantum Mechanics/Molecular Mechanics (QM/MM) [2], Monte Carlo methods (MC) [2, 3], 
Docking and/or Quantitative Structure-Activity Relationships (QSAR) [4-10]. In any case, almost 
all these methods focus on few fundamental aspects including: type (1) methods to quantify the 
molecular structure, type (2) methods to link the structure with the biological activity, and others. 
Several methods of type (1) use QM and/or Graph theory [11-15], whereas the type (2) methods 
use Statistical and/or Machine Learning (ML) techniques. DRAGON [16-18], TOPS-MODE [19-
22], TOMOCOMD [23, 24], CODESSA [25, 26], and MOE [27] are some of the most used 
software that implement type (1) methods. Linear Discriminant Analysis (LDA) implemented in 
STATISCA [28] or ML methods implemented in WEKA [29] are examples of type (2) methods 
and the software used to carry them out.  
 
In this context, different researchers/journals edited important monographic issues in order to 
discuss different computational methods. Some of the most recent have been published by Current 
Topics in Medicinal Chemistry. For instance, Bisson has edited a special issue about 
Computational Chemogenomics in Drug Design and Discovery [30]. Speck-Planche and Cordeiro 
have guest-edited a special issue about computer-aided techniques for the design of antihepatitis C 
agents [31]. Prado-Prado and García-Mera have also guest-edited a special issue about computer-
aided Drug Design and molecular docking for disorders of the central nervous system and other 
diseases [32]. González-Díaz has guest-edited two special issues about mt-QSAR and Complex 
Networks applied to Medicinal Chemistry [33, 34]. In all these issues, and others of the same 
journal, several reviews and research papers have been published in this area [5, 27, 35-69].  
 
In particular, the bio-inspired Artificial-Intelligence (AI) algorithms called Artificial Neural 
Networks (ANNs) are among the most powerful type (2) methods. Important applications of 
ANNs in classifications and feature selection have been published [70-74]. In this paper, we focus 
on one of these methods called MIANN. Thus, we review for the first time many interesting 
aspects of the MIANN strategy including theoretical basis, implementation in web servers, and 
examples of applications in Medicinal and Biological Chemistry. We also report new applications 
of the MIANN strategy in Medicinal Chemistry and the first examples in Physical and Organic 
Chemistry, as well. In so doing, we developed new MIANN models for drug-target interactions, 
several physicochemical properties of surfactants, and large reaction networks in organic 
synthesis. In some of the new examples we also present experimental results which were not 
published up to date.  
2. THE MIANN APPROACH  
MARCH-INSIDE (Markov Chain Invariants for Networks Simulation and Design) is a well-
known type (1) method for QSAR analysis. The method has been mentioned in many recent 
review works published by different groups [65, 75-82]. We can combine MI with different 
Machine Learning algorithms. In particular, we can combine MI with ANNs in order to seek 
QSAR models. The name of this strategy is MIANN (MARCH-INSIDE & ANN models).  
  
2.1. Theoretical Basis of MIANN Analysis  
2.1.1. Parameters for Drug Structure  
The MARCH-INSIDE approach [1, 65, 83] is based on the calculation of the different 
physicochemical molecular properties as an average of atomic properties (wj). For instance, it is 
possible to derive average estimations from molecular descriptors or local indices such as 
electronegativity values 
kχ(G) [84, 85].  
 
 kχ(G) = ∑pk(χj) · χj
 
j=G
 (1) 
  
𝜃𝑘(𝐺) = −∑ 
𝑘𝑝𝑗(𝐺) · log[ 
𝑘𝑝𝑗(𝐺)]
𝑛
𝑗𝜖𝑅
 (2) 
  
𝜋𝑘(𝐺) = ∑  
𝑘𝑝𝑖𝑗(𝐺)
𝑛
𝑖=𝑗𝜖𝑅
 (3) 
 
In this case, wj = χj, the atomic electronegativity. It is also possible to consider isolated atoms 
(k = 0) in a first estimation of the molecular properties 
0χ(G), 0θ(G), or 0π(G). In this case, the 
probabilities 
0
p(χj) are determined without considering the formation of chemical bonds (simple 
additive scheme). However, it is possible to consider the gradual effects of the neighboring atoms 
at different distances in the molecular backbone. In order to reach this goal, the method uses an 
MCM, which determines the absolute probabilities pk(wj) with which the atoms placed at different 
distances k affect the contribution of the atom j to the molecular property in question.  
2.1.2. Parameters for Protein 3D Structures  
In this work, the information about the molecular structure of the proteins is codified using the 
MM method with the 
1∏ matrix (the short-term electrostatic interaction matrix). The matrix 1∏ is 
constructed as a squared matrix (n
x
n), where n is the number of amino acids (aa) in the protein[86-
88]. In previous works we have predicted the protein function based on μk(R) and θk(R) values 3D-
Potentials for different types of interactions or molecular fields derived from 
1∏. The main types 
of the used molecular fields are: electrostatic (E), Van der Waals (vdW) and HINT potential [87, 
89, 90]. In this paper, we have calculated πk(R) and θk(R) values only for E and HINT potentials. 
We have omitted the vdW term due to a simple reason, the HINT potential includes a vdW 
component. The values have been used here as inputs to construct the QSAR model. A detailed 
explanation on the subject has been previously published. As follows, we give the formula for 
πk(R), θk(R) and ξk(R) and some general explanations: 
 
𝜉𝑘(𝑅) = − ∑ 
𝑘𝑝𝑗(𝑅) · 𝜉0(𝑗)
𝑗𝜖𝑅
 (4) 
  
𝜃𝑘(𝑅) = −∑ 
𝑘𝑝𝑗(𝑅) · log[ 
𝑘𝑝𝑗(𝑅)]
𝑛
𝑗𝜀𝑅
 (5) 
  
𝜋𝑘(𝑅) = ∑  
𝑘𝑝𝑖𝑗(𝑅)
𝑛
𝑖=𝑗𝜖𝑅
 (6) 
 
  
It is remarkable that the spectral moments depend on the probability 
k
pij(R) with which the 
effect of the interaction f propagates from amino acid i
th
 to other neighboring amino acids j
th
 and 
returns to i
th
 after k-steps. On the other hand, both the average electrostatic potential and the 
entropy measures depend on the absolute probabilities 
k
pj(R) with which the amino acid j
th
 has an 
interaction of type f with the rest of amino acids. In any case, both probabilities refer to a first (k = 
1) direct interaction of type f between amino acids placed at a distance equal to k-times the cut-off 
distance (rij = k ·rcut-off). The method uses a Markov Chain Model (MCM) to calculate these 
probabilities, which also depend on the 3D interactions between all pairs of amino acids placed at 
a distance rij in r3 in the protein structure. However, for the sake of simplicity, a truncation or cut-
off function αij is applied in such a way that a short-term interaction takes place in a first 
approximation only between neighboring aa (αij = 1 if rij < rcut-off). Otherwise, the interaction is 
banished (αij = 0). The relationship αij may be visualized in the form of a protein structure complex 
network. In this network the nodes are the Cα atoms of the amino acids and the edges connect pairs 
of amino acids with αij = 1. Euclidean 3D space r3 = (x, y, z) coordinates of the Cα atoms of amino 
acids listed on protein PDB files. For the calculation, all water molecules and metal ions were 
removed.[1] The MI[1] software performs all these calculations by evaluation of the summation 
term either for all amino acids or only for some specific groups called regions or orbitals (R). 
These regions are often defined in geometric terms and called core, inner, middle or surface 
region. The protein is virtually divided into the following regions: c corresponds to core, i to inner, 
m to middle, and s to surface regions, respectively. The diameters of the regions are 0 to 25 for 
region c, 25 to 50 for region i, 50 to 75 for region m, and 75 to 100 for region s. These values are 
given in terms of percentage of the longest distance rmax with respect to the center of charge. 
Additionally, we consider the total region (t) that contains all the amino acids in the protein 
(region diameter 0 to 100% of rmax). Consequently, we can calculate different parameters (πk(R), 
ξk(R), and θk(R)) for the amino acids contained in a region (c, i, m, s, or t) and placed at a 
topological distance k within this region (k is the name of the order) [90-94]. In this work, we 
calculated a total of 90 indices (3 types of indices x 5 types of regions x 6 higher order considered) 
for each protein.  
2.2.2. Pseudo-Folding Parameters for Proteins Sequences  
The MARCH-INSIDE approach is based on the calculation of the different molecular 
parameters of both proteins (Ps) and drugs and/or organic ligands (Ls) of proteins [65, 82]. In this 
sense, different parameters of protein pseudo-folding in 2D lattice-like spaces have been used 
before in proteome research [95]. On the other hand, in previous works, we have predicted a 
protein function based on 3D-potentials for different types of interactions. The main types of 
potentials used are the averaged values of electrostatic, Van der Waals and HINT potentials [96, 
97]. In this paper, we combine for the first time the pseudo-folding electrostatic ξk potentials of 
protein sequences with average electronic parameters of drugs. These values of protein sequences 
were used as inputs to construct the QSAR model together with the parameters of drug structure. 
The key of the method is to overcome the higher dimension space bottleneck after previous 
grouping of the monomers (amino acids) into four groups. These four groups characterize the 
physicochemical nature of the amino acids as: polar, non-polar, acid, or basic. Classification of 
monomers (amino acids) as acid or basic prevails over polar/non-polar classification in such a way 
that the four groups do not overlap each other. Subsequently, each amino acid in the sequence is 
placed in a Cartesian 2D space starting with the first monomer at the (0, 0) coordinates. The 
coordinates of the successive amino acids are calculated following simple heuristics, in such a way 
it can be used for a DNA [98]. Secondly, the method uses the matrix 
1∏, which is a squared matrix 
to characterize the protein sequence pseudo-folding into a 2D lattice-like space (see graphs). 
Please, note that the number of nodes (n) in the graph may be equal or even smaller than the 
number of amino acids in the protein sequence. Accordingly, the matrix 
1∏ contains the 
probabilities 
1
pij to reach a node ni moving throughout a walk of length k = 1 from another node nj: 
 
𝑝𝑖𝑗(𝑃𝑛) =
𝑄𝑗(𝑃𝑛)
∑ 𝛼𝑖𝑙 · 𝑄𝑙(𝑃𝑛)
𝑛
𝑚=𝑙
 (7) 
  
Where, Qj is the charge of the node nj and αij equals to 1 if the nodes ni and nj are adjacent in 
the graph and equals to 0 otherwise. The charge of the node Qj is equal to the sum of the charges 
of all amino acids projected over this node after protein sequence pseudo-folding. We can list all 
these Qj values calculating the elements of a vector of electrostatic potentials q0 ≡ [Qj/dj] ≡ [Q1/d1, 
Q2/d2,...Qj/dj, Qj+1/dj+1, ...Qn/dn] being dj the Euclidian distance from the node j
th
 and the center of 
coordinates (0, 0) in the 2D pseudo-folding space. Afterwards, the calculation of the average 
electrostatic potentials of protein pseudo-folding is carried out directly.  
 
𝜉𝑘 = 𝐩0 
𝑡.𝑘∏ · 𝐪0 = 𝐩0 
𝑡 · ( 1∏) 𝑘 · 𝐪0= ∑ 𝑝𝑘(𝑗) · 𝜉(𝑗)
𝑛
𝑗=𝑙𝜖𝑅
 (8) 
 
The average general potentials depend on the initial absolute probabilities p0(j) and the total 
potential with which all the amino acids projected over the lattice node j
th
 interact with the rest of 
amino acids projected over other nodes of the space. These are the probabilities with which the 
amino acids interact with other amino acids placed at a topological distance dij equal to k-times the 
cut-off distance (dij = k). These probabilities are the elements of the vector p0 ≡ [Qj/dj] ≡ [Q1/d1, 
Q2/d2,...Qj/dj, Qj+1/dj+1, ...Qn/dn].  
2.2.4. Parameters of PPIs Used in the MIANN Analysis  
In principle, we can use as input for the MIANN analysis of PPIs all types of PPI invariants 
calculated with MI. However, the only MI parameter calculated with MI that has been used for a 
MIANN analysis of PPIs until now is the entropy θk(R). The used entropy parameters represent the 
average electrostatic entropy (θ) due to the interactions between all pairs of amino acids allocated 
inside a specific protein region (R) and placed at a distance k from each other. In order to describe 
PPIs we need to use θk(R) values of two proteins, θk(
1
R) for protein 1 and θk(
2
R) for protein 2, in 
order to generate structural parameters describi>Curr. Top. Med. Chem.</secondary-
title></titles><periodical><full-title>Curr. Top. Med. Chem.</full-title></periodical> 
<pages>1883-8</pages><volume>12</volume><number>17</number><dates><year>2012 
</year></dates><pub-location>Netherlands</pub-location><isbn>1873-4294 (Electronic)&#xD; 
1568-0266 (Linking)</isbn><accessio
n-θk(R): PPI Average Entropy Invariant (ti = a), PPI Entropy 
Difference Invariant (ti = d), and PPI Entropy Product Invariant (ti = p):  
 
 𝛼𝜃𝑘(𝑅) =  
𝛼𝜃𝑘( 
1𝑅1,  
2𝑅1) =
1
2
[𝜃𝑘( 
1𝑅1) + 𝜃𝑘( 
2𝑅1)] (9) 
  
 𝑑𝜃𝑘(𝑅) =  
𝑑𝜃𝑘( 
1𝑅1,  
2𝑅1) = |[𝜃𝑘( 
1𝑅1) − 𝜃𝑘( 
2𝑅1)]| (10) 
  
 𝑝𝜃𝑘(𝑅) =  
𝑝𝜃𝑘( 
1𝑅1,  
2𝑅1) = 𝜃𝑘( 
1𝑅1) · 𝜃𝑘( 
2𝑅1) (11) 
 
Notably, in order to guarantee that these parameters are invariant to protein labeling as 1 or 2, 
we have to always use the same 
1
R = 
2
R = R and k1 = k2 = k values. In order to calculate the θk(R) 
values for each protein, the method uses as a source of protein macromolecular descriptors the 
stochastic matrices 
1∏e built up as squared matrices (n x n), where n is the number of amino acids 
(aa) in the protein. The subscript e points to the electrostatic type of molecular force field. In 
previous works we have predicted the protein function based on θk(R) values for different types of 
interactions or molecular fields. The main types of molecular fields used are the following: 
electrostatic, vdW, and HINT entropies.  
2.2.5. ANN Analysis in the Context of the MIANN Strategy  
On the one hand, the MIANN strategy involves using as inputs, in order to train the ANNs, the 
MI parameters of the r
th
 drugs or protein ligands (Lr) in general: 
kχ(Lr), 
kθ(Lr), or 
kπ(Lr). On the 
other hand, we should use the MI parameters of s
th
 protein sequences or 3D structures: 
kξ(Ps), 
kθ(Ps), or 
kπ(Ps). In the case of a Linear ANN (LNN), the models may have the following general 
formulae for the cases of a drug, protein, DPIs, or PPI analysis (examples using only entropies 
kθ(Lr) for drugs, ligands, or low-weight molecules and 
kθ(Ps) for proteins):  
 
𝑆(𝐿𝑟)𝑝𝑟𝑒𝑑 = ∑ 𝛼𝑘 ·  
𝑘𝜃(𝐿𝑟) + 𝑐0
5
𝑘=0
 (12) 
  
𝑆(𝑃𝑠)𝑝𝑟𝑒𝑑 = ∑ 𝑏𝑘 ·  
𝑘𝜃(𝑃𝑠) + 𝑐0
5
𝑘=0
 (13) 
  
𝑆(𝐷𝑃𝐼𝑟𝑠)𝑝𝑟𝑒𝑑 = ∑ 𝛼𝑘 ·  
𝑘𝜃(𝐿𝑟) + ∑ 𝑏𝑘 ·  
𝑘𝜃(𝑃𝑠) +
5
𝑘=0
𝑐0
5
𝑘=0
 (14) 
  
𝑆(𝑃𝑃𝐼𝑟𝑠)𝑝𝑟𝑒𝑑 = ∑ 𝛼𝑘 ·
1
2
[𝜃𝑘(𝑃𝑟) + 𝜃𝑘(𝑃𝑠)]
5
𝑘=0
+ ∑ 𝑏𝑘 · |𝜃𝑘(𝑃𝑟) − 𝜃𝑘(𝑃𝑠)| + ∑ 𝑐𝑘 · 𝜃𝑘(𝑃𝑟) · 𝜃𝑘(𝑃𝑠) + 𝑑0
5
𝑘=0
5
𝐾=0
 
(15) 
 
The model deals with the classification of a set of compounds, proteins, DPIs, or PPIs, with or 
without affinity to different protein targets. A dummy input variable Affinity Class (AC) codifies 
the affinity; AC = 1 for well-known DPIs and AC = 0 otherwise. This variable indicates either 
high (AC = 1) or low (AC = 0) affinity of the drug to the target protein. The parameter S(DPIrs)pred 
is the output of the model and it is a continuous and dimensionless score that gives higher values 
for DPIs and lower values for nDPIs. In the model, ak, bk, and c0 represent the coefficients of the 
MIANN function determined by the LNN technique using the STATISTICA 6.0 software package 
[99]. We can check Specificity, Sensitivity, total Accuracy, or Area Under ROC curve (AUROC) 
to determine the quality-of-fit to data in the training and external validation series. DPIs and nDPIs 
cases in the validation series should not be used to train the model.  
2.2.6. Data Set Useful for the MIANN Analysis  
In principle, we can withdraw a dataset for the MIANN analysis from different public 
resources. However, in almost all cases we have obtained the datasets from the Drug Bank (DB, 
http://www.drugbank.ca/) an online source available for public research. From this website, we 
obtained a list of all drugs approved by the US Food and Drug Administration (US FDA, 
http://www.fda.gov/). We only included DPIs with known affinity of drugs to target with a known 
3D structure available in the Protein Data Bank (PDB, http://www.pdb.org)[100]. The data set 
contains more than >300 drugs with their respective >300 molecular targets. The data also contain 
negative cases made up of active compounds for known targets but not marketed as active against 
other targets (nDPIs). Therefore, we were able to collect over >6,000 cases (DPIs/nDPIs). Due to 
space constraints, the names, DB codes, SMILE codes, target function, and target PDB code for 
both drugs and/or targets were depicted in the supplementary material file SM2.pdf;.  
  
3. MIANN MODELS IN MEDICINAL CHEMISTRY  
3.1. Examples of ANN and MIANN Models in QSAR and mt-QSAR  
3.1.1. ANN Model of Drugs Multiplex Toxic Effects  
ANN models can be used not only in QSAR but also in mt-QSAR. For instance, in ref. [101], 
the authors reported the most recent upgrade of the ANN-based strategies for mt-QSAR. In so 
doing, they used the TOPS-MODE approach to calculate drug molecular descriptors and the 
STATISTICA software to seek different MIANN models such as Linear Neural Network (LNN), 
Radial Basis Function (RBF), Probabilistic Neural Networks (PNN) and Multi-Layer Perceptrons 
(MLP). The best model found was the LNN, which correctly classified 8,258 out of 9,000 
(Accuracy = 93.0%) multiplexing assay endpoints of 7,903 drugs (including both training and test 
series). Each endpoint corresponds to one out of 1,418 assays, 36 molecular or cellular targets, 46 
standard type measures, in two possible organisms (human and mouse). Secondly, we have 
determined experimentally, for the first time, the values of EC50 = 11.41 μg/mL and Cytotoxicity = 
27.1% for the drug G1 over Balb/C mouse spleen macrophages using flow cytometry. In addition, 
we have used the LNN model to predict the G1 activity in 1,265 multiplexing assays not measured 
experimentally (including 152 cytotoxicity assay endpoints). Both experimental and theoretical 
results point out a low macrophage cytotoxicity of G1. This work breaks new ground for the 'in 
silico' multiplexing screening of large libraries of compounds. The same idea behind the 
application of ANN models in QSAR and mt-QSAR can be applied to seek MIANN models. As 
follows we review some MIANN models in QSAR and mt-QSAR.  
3.1.2. MIANN Model of Drugs with Anti-Cancer Activity  
Developing a model for predicting anti-cancer activity of any classes of organic compounds 
based on molecular structure is a very important goal for a medicinal chemist. Nevertheless, the 
structural diversity of compounds is so vast that we may need non-linear models such as ANNs 
instead of linear ones. In a previous work we have used the MIANN strategy to solve this problem 
[102]. In this work, the MIANN analysis was used to model the anti-cancer activity of organic 
compounds, which has shown a high average accuracy of 93.79% (training performance) and 
predictability of 90.88% (validation performance) for the 8:3-MLP topology with different training 
and predicting series. This MIANN model compares favorably with respect to a previous linear 
model that showed only 80.49% of accuracy and 79.34% of predictability [103]. (Fig. 1) depicts a 
graphical abstract of this work. The present MIANN model based on the SmartMLP approach 
employed shorter training times of only 10h, while previous models have given accuracies of 70-
89% only after 25-46 h of training. In order to illustrate the practical use of the model in 
Bioorganic Medicinal Chemistry, we report the in silico prediction, and in vitro evaluation of six 
new synthetic tegafur analogues having IC50 values in a broad range between 37.1 and 138 μg/mL 
for leukemia (L1210/0) and human T-lymphocyte (Molt4/C8, CEM/0) cells. Theoretical 
predictions coincide very well with experimental results.  
  
 
 
 
Fig. (1). Graphical abstract of the first work with a MIANN model.  
3.1.3. MIANN Approach to mt-QSAR of Multi-Target AntiParasite Effects  
There are many pathogen parasite species with different susceptibility profile to anti-parasitic 
drugs. Unfortunately, most QSAR models predict the biological activity of drugs against only one 
parasite species. Consequently, predicting the probability with which a drug is active against 
different species with a single unified model is a goal of major importance. In so doing, we used 
the MIANN strategy to seek the first mt-QSAR model for 500 drugs tested in the literature against 
16 parasite species and other 207 drugs not tested in the literature using spectral moments. We 
tested different ANN topologies such as LNN and MLP, RBF and Probabilistic Neural Network 
(PNN), see (Fig.2). The best MIANN model found had an overall training performance of 87%. 
The present work reports the first attempts to calculate within unified framework probabilities of 
anti-parasitic action of drugs against different parasite species based on a spectral moment analysis 
[104].  
 
 
 
Fig. (2). Different ANN topologies used in MIANN studies.  
  
3.2. Examples of MIANN Models of DPIs  
3.2.1. ANN Models of DPIs  
Prediction of drug-target proteins interactions (DPIs) is very important for drug discovery. The 
importance of this topic increases if we take into consideration the high number of experimental 
assays that are necessary in order to elucidate all possible relationships in DPI complex networks. 
See for instance, the high complexity of bipartite graph constructed in Ref. [105] in order to 
represent all DPIs between drugs approved by the US FDA with different target proteins. Hence, 
the development of new computational methods able to accurately predict DPIs is of major interest 
[106]. We can discriminate between DPIs of drugs with high affinity and those pairs of drugs with 
no affinity to different targets (nDPIs) with models that use as input structural parameters of both 
drugs and protein targets. This type of QSAR-based methods for prediction of DPIs is a particular 
case of mt-QSAR models [1, 107-109]. To this end, we should take into consideration that they 
allow the study of multiple target proteins and allow the reconstruction of the respective DPI 
complex networks. Conversely, almost all QSAR techniques allow the prediction of DPIs for only 
one target [104, 110-119]. We can use ANN algorithms to seek mt-QSAR models of DPIs. For 
instance, the researchers combined in Ref. [120] the mt-QSAR ideas with an ANN algorithm to 
study compounds active against Colorectal Cancer (CRC). CRC is one of the most studied cancers 
because of its high prevalence and number of deaths. The same authors [121] used ANNs to 
construct an mt-QSAR model of DPIs for drugs with activity in patients with the Acquired 
Immunodeficiency Syndrome (AIDS). In both works, the ANN models found classified more than 
90% of active and inactive compounds in training and prediction sets. As follows we review some 
MIANN models for DPIs. (Fig. 3) shows the general workflow used to seek a MIANN model of 
DPIs.  
  
 
 
 
Fig. (3). Workflow of the MIANN strategy for the drug-target interaction network problem. 
3.2.2. MI-DRAGON: MIANN Models for DPIs  
In a more recent work [122], the scientists combined the MARCH-INSIDE method with the 
DRAGON software to create 2D MI-DRAGON, a new predictor for DPIs. The MARCH-INSIDE 
(MI) software was used to calculate 3D structural parameters for targets and the DRAGON 
software was used to calculated 2D molecular descriptors of drugs. Both classes of parameters 
were used as input of different ANN algorithms to seek an accurate non-linear mt-QSAR 
predictor. The best ANN model found is a MLP with profile MLP 21:21-31-1:1. This MLP 
classifies correctly 303 out of 339 DPIs (Sensitivity = 89.38%) and 480 out of 510 nDPIs 
(Specificity = 94.12%), corresponding to training Accuracy = 92.23%. The validation of the model 
was carried out by means of external predicting series with Sensitivity = 92.18% (625/678 DPIs; 
Specificity = 90.12% (730/780 nDPIs) and Accuracy = 91.06%. 2D MI-DRAGON offers a good 
opportunity for fast-track calculation of all possible DPIs of one drug enabling to re-construct 
large drug-target or DPIs complex networks. For instance, we reconstructed the complex network 
of the US FDA benchmark dataset with 855 nodes (519 drugs + 336 targets). Finally, the practical 
use of 2D MI-DRAGON was illustrated in one theoretic-experimental study. We reported the 
prediction, synthesis, and pharmacological assay of 10 different oxoisoaporphines with MAO-A 
inhibitory activity. The most active compound OXO5 presented IC50 = 0.00083 μM, notably better 
than the control drug Clorgyline.  
  
3.2.3. NL MIND-BEST: the MIANN Model of DPIs Implemented in a Web Server  
In references [123, 124], the authors developed both linear and MIANN models for DPIs using 
2D physicochemical properties of drugs, but 3D physicochemical properties (electrostatic 
potentials) of the protein. The accuracy of the best linear model was 94.4% (3,859/4,086 cases) for 
training and 94.9% (1,909/2,012 cases) for the external validation series. In addition, the model 
was implemented into the Web portal Bio-AIMS. In so doing, we called the new web server 
MIND-BEST [123], acronym of MARCH-INSIDE Nested Drug-Bank Exploration & Screening 
Tool. The URL for this server is http://bio-aims.udc.es/MIND-BEST.php. This on-line tool is 
based on PHP/HTML/Python and MARCH-INSIDE routines. This work also illustrates with two 
examples the practical uses of this server. The experiment 1 includes MIND-BEST prediction, 
synthesis, characterization, and MAO-A and MAO-B pharmacological assay of eight rasagiline 
derivatives, promising for anti-Parkinson drug design. Experiment 2 reports the sampling, parasite 
culture, sample preparation, 2-DE, MALDI-TOF and -TOF/TOF MS, MASCOT search, 3D 
structure modeling with LOMETS, and MIND-BEST prediction for different peptides found in the 
proteome of the bird parasite Trichomonas gallinae, which is promising for the discovery of 
antiparasite drug targets.  
 
We also published the MIANN version of the previous web server by the name NL MIND-
BEST [124]. In so doing, we solved the DPI problem using the MIANN methodology. In other 
words, we followed the same flowchart as in MIND-BEST to calculate the parameters of drugs 
and proteins, but using different non-linear ANNs to seek the model. The best MIANN model 
found was the MLP 20:20-15-1:1. This MLP correctly classifies 611 out of 678 DPIs (Sensitivity 
= 90.12%) and 3,083 out of 3,408 nDPIs (Specificity=90.46%), corresponding to training 
Accuracy = 90.41%. The validation of the model was carried out by means of external predicting 
series. The model correctly classifies 310 out of 338 DPIs (Sensitivity = 91.72%) and 1,527 out of 
1,674 nDPI (Specificity=91.22%) in validation series, corresponding to total Accuracy = 91.30% 
for validation series (Predictability). This model favorably compares with other ANN models 
developed in this work and Machine Learning classifiers published before to address the same 
problem in different aspects. This web server is located at the URL: http://bio-aims.udc.es/NL-
MIND-BEST.php. (Fig.4) shows the online user interface for the web server NL MIND-BEST. 
We also illustrated here, with two practical examples, the potential uses of this server. In 
experiment 1, we report for the first time the Quantum QSAR study, synthesis, characterization, 
and experimental assay of antiplasmodial and cytotoxic activities of oxoisoaporphine alkaloids 
derivatives as well as the NL MIND-BEST prediction of potential target proteins. In experiment 2, 
we report the sampling, parasite culture, sample preparation, 2-DE, MALDI-TOF, and -TOF/TOF 
MS, MASCOT search, MM/MD 3D structure modeling, and NL MIND-BEST prediction for 
different peptides found in the proteome of the human parasite Giardia lamblia, which is 
promising for the discovery of anti-parasite drug targets.  
  
 
 
 
Fig. (4). Online user interface for the web server NL MIND-BEST. 
3.2.4. MIANN Model of DPIs Based on Entropy Parameters  
In all these works, we used 2D/3D physicochemical parameters of drugs and proteins 
calculated with the MI software to apply the MIANN startegy. However, MI calculates not only 
physiochemical parameters from a more classical point of view, but also different theoretic 
invariants of molecular structure, which are useful to solve the DPI problem with QSAR models. 
For instance, Ref. [125] reported an alternative MIANN solution of the DPI problem using entropy 
parameters of both drug and target structure. The best MIANN model found is the MLP 32:32-15-
1:1. This MLP correctly classifies 623 out of 678 DPIs (Sensitivity = 91.89%) and 2,995 out of 
3,234 nDPIs (Specificity = 92.61%), corresponding to training Accuracy = 92.48%. The validation 
of the model was carried out by means of external predicting series. The model correctly classifies 
313 out of 338 DPIs (Sensitivity = 92.60%) and 1,411 out of 1,534 nDPIs (Specificity = 91.98%) 
in validation series, corresponding to total Accuracy = 92.09% for validation series 
(Predictability). The authors illustrated with two practical examples the use of this model. The first 
example includes the prediction, synthesis, characterization, and MAO-A and MAO-B 
pharmacological assay of 10 rasagiline derivatives promising for anti-Parkinson drug design. The 
second example contains the sampling, parasite culture, SEC and 1DE sample preparation, 
MALDI-TOF MS and MS/MS analysis, MASCOT search, MM/MD 3D structure modeling, and 
QSAR prediction for different peptides of hemoglobin found in the proteome of the human 
parasite Fasciola hepatica. This protein is promising for the discovery of anti-parasite drug 
targets.  
4. MIANN MODELS IN BIOLOGICAL CHEMISTRY  
4.1. Example of MIANN Model of PPIs  
The first MIANN model of PPIs reported up to date was introduced to study PPIs in the 
parasite Trypanosoma. Trypanosoma brucei causes African trypanosomiasis in human (HAT or 
African sleeping sickness) and Nagana in cattle. The disease threatens over 60 million people and 
uncounted numbers of cattle in 36 countries of sub-Saharan Africa and has a devastating impact on 
human health and the economy. On the other hand, Trypanosoma cruzi is responsible in South 
America for Chagas disease, which can cause acute illness and death, especially in young children. 
In this context, the discovery of novel drug targets in Trypanosome proteome is a major focus for 
the scientific community. Recently, many researchers have spent important efforts on the study of 
PPIs in pathogen Trypanosome species concluding that the low sequence identities between some 
parasite proteins and its human host render these PPIs as highly promising drug targets. To the 
best of our knowledge, there are no reported general models to predict Unique PPIs in 
Trypanosome (TPPIs) before the MIANN model published by our group. On the other hand, the 
3D structure of an increasing number of Trypanosome proteins is being reported in databases. In 
this sense, the introduction of a new model to predict TPPIs from the 3D structure of proteins 
involved in PPI is very important. For this purpose, we introduced new protein-protein complex 
invariants based on the Markov average electrostatic potential ξk(Ri) for amino acids located in 
different regions (Ri) of i-th protein and placed at a distance k from each other. (Fig. 5) illustrates 
the workflow used in this previous work [126].  
  
 
 
 
Fig. (5). Worflow used in the development of the MIANN server TrypanoPPI.   
We calculate more than 30 different types of parameters of 7,866 protein pairs (1,023 TPPIs 
and 6,823 non-TPPIs) from more than 20 organisms, including parasites and human or cattle hosts. 
We found a very simple linear model that predicts above 90% of TPPIs and non-TPPIs both in 
training and independent test sub-sets using only two parameters. The parameters were 
dξk(s) = 
|ξk(s1) – ξk(s2)| which are the absolute difference between the ξk(si) values on the surface of the two 
proteins of the pairs. We also tested non-linear ANN models for comparison purposes but the LNN 
model gives better results. We implemented this predictor in the web server named TrypanoPPI, 
freely available to public at http://bio-aims.udc.es/TrypanoPPI.php (see user interface in Fig.6). 
This is the first model that predicts how unique is a protein-protein complex in Trypanosome 
proteome with respect to other parasites and hosts, providing new opportunities for the discovery 
of anti-trypanosome drug targets.  
 
 
 
Fig. (6). Online user interface of the MIANN server TrypanoPPI. 
4.2. Example of a MIANN Model for Protein vs.Organism Self/Non-Self Analysis  
Infections caused by human parasites (HPs) affect the poorest 500 million people worldwide 
and unfortunately chemotherapy has become expensive, toxic, and/or less effective due to drug 
resistance. On the other hand, many 3D structures remain without function annotation in the PDB. 
We need theoretical models to quickly predict biologically relevant Parasite Self Proteins (PSP), 
which are expressed differently in a given parasite and are dissimilar to proteins expressed in other 
parasites and have a high probability to become new vaccines (unique sequence) or drug targets 
(unique 3D structure). We published a MIANN model for PSPs in eight different HPs (Ascaris, 
Entamoeba, Fasciola, Giardia, Leishmania, Plasmodium, Trypanosoma, and Toxoplasma) with 
90% accuracy for 15,341 training and validation cases [127]. The input parameters are the spectral 
moments of the Markov transition matrix for electrostatic interactions associated with the protein 
residue complex network calculated with the MARCH-INSIDE software. (Fig. 7) depicts the 
workflow used for the development of the model.  
  
 
 
 
Fig. (7). Workflow used for the development of the MIANN server MISSProt-HP. 
  
We implemented this model in a new web-server called MISS-Prot (MARCH-INSIDE Scores 
for Self-Proteins). MISS-Prot was programmed using PHP/HTML/Python and MARCH-INSIDE 
routines and is freely available at: http://bio-aims.udc.es/MISSProt-HP.php. This server is easy to 
use by non-experts in Bioinformatics who can carry out automatic online upload and prediction 
with 3D structures deposited at PDB (mode 1). We can also study outcomes of Peptide Mass 
Fingerprinting (PMFs) and MS/MS for query proteins with unknown 3D structures (mode 2). We 
illustrated the use of MISS-Prot in experimental and/or theoretical studies of peptides from 
Fasciola hepatica cathepsin proteases or present in 10 Anisakis simplex allergens (Ani s 1 to Ani s 
10). In doing so, we combined electrophoresis (1DE), MALDI-TOF Mass Spectroscopy, and 
MASCOT to seek sequences, Molecular Mechanics + Molecular Dynamics (MM/MD) to generate 
3D structures and MISS-Prot to predict PSP scores. MISS-Prot also allows the prediction of PSP 
proteins in 16 additional species including parasite hosts, fungi pathogens, disease transmission 
vectors, and biotechnologically relevant organisms. (Fig. 8) shows the online user interface of the 
MIANN server.  
 
 
 
Fig. (8). Online user interface of the MIANN server MISSProt-HP.  
4.3. Example of a MIANN Model for Enzyme Class Prediction  
4.3.1 EnzClassPred Server  
The server EnzClassPred is available in the Bio-AIMS portal (http://bio-
aims.udc.es/EnzClassPred.php). This MIANN server is a free on-line public tool based on 
PHP/HTML/Python and MARCH-INSIDE routines. The server is based on the models that we 
have published before [128]. The input of this server is a PDB id, it can accept maximum 50 
entries; for each of them it checks whether the structure has an annotation in the PDB, and if the 
annotation is present it reports the annotation of the PDB; otherwise it uses the model we have 
developed and makes a prediction of the structure. (Fig. 9) shows the online user interface of the 
MIANN server EnzClassPred. When the calculation is launched the user is redirected to the output 
page; on the top of the output page there is a direct link to the pdb page of each structure, the 
resume of the model and the EC classification. Below the classification there is a box where it can 
be specified whether the protein is present in the PDB or not, as already that if the protein is not 
met, the server activates the model developed earlier thus giving a prediction on the possible 
classification of the structure. To seek the MIANN model, we have calculated the 3D entropy and 
spectral moments of 4,755 proteins (859 enzymes and 3,896 non-enzymes); all these structures 
were retrieved from the PDB and divided into a positive series of enzymes and a negative series of 
non-enzymes. The LDA model found is very simple (three variables) and at the same time is able 
to predict the first EC number with an overall accuracy of 79% for our data set divided into both 
training and external validation series. In addition, the best non-linear ANN model is notably more 
complex but has an overall accuracy of >98%.  
 
 
 
Fig. (9). Online user interface of the MIANN server EnzClassPred. 
5. MIANN MODELS IN PHYSICAL CHEMISTRY  
5.1. MIANN QSPR Model of Self-Assembly in Surfactants  
5.1.1. Short Introductory Note  
Molecular self-assembly is the process through which single molecules arrange themselves 
spontaneously into different structures [129]. One of the most ubiquitous self-assembly processes 
in Physical Chemistry is the hierarchical organization of amphiphilic molecules into a huge variety 
of patterns as micelles, rods or liposomes among others [130, 131]. Such property has recently 
been employed to design and fabricate for a wide range of biotechnological applications because 
of their relatively simple structures and easy scale up commercial productions [132]. Some drugs 
exhibit amphiphile behavior, they tend to self-assembly, usually in a small aggregation number, 
when dispersed in aqueous solution in a surfactant-like manner [133]. Although drug micelles 
normally form at concentrations well above the concentration of the drug appearing in body 
systems, micelles may be present in the pharmaceutical formulation to overcome different 
challenges including poor bioavailability, stability, side effects or plasma fluctuations of drugs. 
Imipramine hydrochloride is one of the main tricyclic antidepressant drugs. It is used in clinics as 
an antidepressant and antipsychotic drug. It possesses a hydrophobic nitrogen-containing 
heterocycle bound to a short chain carrying a charged amino group [134]. It is widely recognized 
that the current experimental resources will not be adequate for the vast range of new drug 
molecules synthesized every day. An especially desirable feature for the pharmaceutical industry is 
the ability to know a priori and in situ the self-assembly properties of these compounds under 
different conditions.  
5.1.2. Materials  
Imipramine, 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine 
hydrochloride of at least 98.5% purity were purchased from Sigma Chemical Co. and used without 
further purification. The drug was used as received. All measurements were performed using 
distilled water with conductivity below 3 μS·cm-1 at 298.15 K.  
5.1.3. Experimental Methods  
Electrical conductivities were measured using a Kyoto Electronics conductometer model CM-
117 with a K-121 cell type. The cell constant was determined using KCl solutions. All 
measurements were taken in a PolyScience Model PS9105 thermostated water bath, at a constant 
temperature within ± 0.05 K. The determination of the isotherms of conductivity was carried out 
by continuous dilution of a concentrated sample prepared by weight. The expected duration of the 
dynamics processes varies from10
-8
 to 10
-2
 s, i.e., between typical aggregate-solvent exchange 
time of amphiphilic molecules and typical fusion time of the corresponding aggregates. Thus, the 
equilibrium is guaranteed a few seconds after dilution [135]. Dynamic light scattering 
measurements were made at 298.0 ± 0.1 K and at a scattering angle of 90º. Time correlation was 
analyzed by an ALV-5000 (ALV-GmbH) instrument with vertically polarized incident light of 
wavelength λ = 488 nm supplied by a CW diode-pumped Nd; the YAG solid-state laser (Coherent. 
Inc.) operated at 400 mW. Data were analyzed to determine diffusion coefficients using the 
CONTIN software packages. Hydrodynamic radii were calculated from measuring diffusion 
coefficients by means of the Stokes- Einstein equation.  
5.1.4. Experimental Results  
For the studied temperature range, the electrical conductivity concentration dependence shows 
a monotonic increase with a slight gradual decrease in slope, as expected for self-assembly 
processes [136, 137]. Critical micellar concentrations (cmc) values were calculated by fitting the 
experimental isotherms to the non-linear function obtained by direct integration of a Boltzmann-
type sigmoid function[138]. The cmc obtained by this method as a function of temperature show 
the typical U-shaped behavior observed for the critical micelle concentration of surfactant 
molecules, see (Fig. 10).  
  
 
 
 
Fig. (10). Top: Fit of the temperature dependence of lnxcmc using the equation (16); and Botton: Size distribution of a 
solution of imipramine with a concentration twice the cmc.  
For those systems, the cmc decrease with temperature increase like that observed in (Fig. 10) at 
T<297 K- is typically explained by the net rupture of structured water surrounding the 
hydrophobic moiety, thus promoting aggregation. The opposite trend at higher temperatures is 
typically due to the dominant effect coming from the dehydration of the charged head groups 
accompanied of the subsequent electrostatic repulsion [139]. Thermodynamic parameters 
corresponding to the aggregation process can be obtained by analyzing the cmc dependence on 
temperature by means of [140]:  
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where the degree of ionization dependence on temperature, β = β0 + β1T and the standard change in 
isobaric molar heat capacity, ∆𝐶𝑃,𝑚
0 = ∆𝐶𝑃,𝑚
0∗ + 𝛼(𝑇 − 𝑇∗), are explicitly considered. ln 𝑥𝑐𝑚𝑐
∗  and 
T
* 
correspond to the minimum value. (Fig. 10) shows the fair fit of equation (16) to experimental 
data. Results obtained from the fitting were: 297.4 K, -7.11, -363.41 J mol
-1
 K
-1
 and -2.67 for T
*
, 
ln 𝑥CAC
∗  , ∆𝐶𝑃,𝑚
0∗  and α / R  respectively. The standard enthalpic and entropic changes due to 
aggregates formation at the minimum value are given by:  
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The dependence of the thermodynamic functions on temperature is obtained from the following 
expressions:  
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∆𝑆𝑚
0 = ∆𝑆𝑚
0∗ + ∆𝐶𝑃,𝑚
0∗ ln(𝑇/𝑇∗) + 𝛼{𝑇 − 𝑇∗ − 𝑇∗ ln(𝑇/𝑇∗)} (20) 
 
And the standard Gibbs energy of aggregates formation is given by:  
 
∆𝐺𝑚
0 = ∆𝐻𝑚
0 − 𝑇∆𝑆𝑚
0  (21) 
 
Heat capacity, enthalpy, entropy and standard free energy data corresponding to the 
aggregation process are listed in (Table 1). ∆𝐻𝑚
0  and ∆𝑆𝑚
0  are quite sensitive to temperature. ∆𝐻𝑚
0  
values indicate that the imipramine aggregation is increasingly more exothermic at higher 
temperatures. Negative ∆𝐻𝑚
0  values suggest the importance of London-dispersion interactions as 
the major force for aggregation. However, ∆𝑆𝑚
0  decreased with temperature and remained positive. 
This aggregation is entropic driven at low temperatures whereas enthalpic contributions become 
more important at high temperatures. The higher order of water molecules around hydrocarbon 
chains at lower temperatures could explain this. This fact has been observed for other drugs [141, 
142]. In (Table 1) we show the values of critical micelle concentration (cmc in mol kg
-1
), heat 
capacity, ∆𝐶𝑃,𝑚
0  (J mol
-1
 K
-1
), ∆𝐻𝑚
0  (J mol
-1
), ∆𝑆𝑚
0  (J mol
-1
 K
-1
), and standard free energy, ∆𝐺𝑚
0  (J 
mol
-1
) obtained for imipramine at different temperatures, T (K).  
Table 1. Values of Different Parameters Obtained for Imipramine at Different Temperatures 
T (K) cmc ∆𝐶𝑃𝑚
0  ∆𝐻𝑚
0  ∆𝑆𝑚
0  ∆𝐺𝑚
0  β S(nm2) N 
         
288.2 0.051 157.71 11696 51.32 26483 0.448 15.7632 9 
290.2 0.0478 202.09 12073 50.01 26582 0.4534 15.7632 9 
293.2 0.0475 268.66 12559 47.48 26479 0.4615 15.7632 9 
296.2 0.0462 335.23 13649 44.31 26771 0.4696 15.7632 9 
298.2 0.0444 379.61 14376 41.83 26849 0.475 15.7632 9 
301.2 0.046 446.18 15467 37.6 26790 0.4831 15.7632 9 
303.2 0.048 490.56 16193 34.44 26632 0.4885 15.7632 9 
305.2 0.0481 534.94 16920 31 26379 0.4939 15.7632 9 
308.2 0.0539 601.51 18010 25.34 25819 0.502 15.7632 9 
313.2 0.0623 712.46 19827 14.61 24402 0.5155 15.7632 9 
𝑆𝑖𝑗(𝑍𝑖𝑗 > 0) 
T(K) cmc ∆𝐶𝑃𝑚
0  ∆𝐻𝑚
0  ∆𝑆𝑚
0  ∆𝐺𝑚
0  β S(nm2) N 
288.2 0.05311 -0.0106 0.0322 0.02195 0.03427 0.06583 0.07995 0.05924 
290.2 0.0285 -0.0352 0.00759 -0.0027 0.00967 0.04123 0.05534 0.03463 
293.2 -0.0084 -0.0721 -0.0293 -0.0396 -0.0272 0.00432 0.01843 -0.0023 
296.2 -0.0453 -0.109 -0.0662 -0.0765 -0.0642 -0.0326 -0.0185 -0.0392 
298.2 -0.0699 -0.1336 -0.0908 -0.1011 -0.0888 -0.0572 -0.0431 -0.0638 
301.2 -0.1068 -0.1705 -0.1277 -0.138 -0.1257 -0.0941 -0.08 -0.1007 
303.2 -0.1314 -0.1952 -0.1524 -0.1626 -0.1503 -0.1187 -0.1046 -0.1253 
305.2 -0.1561 -0.2198 -0.177 -0.1872 -0.1749 -0.1433 -0.1292 -0.1499 
308.2 -0.193 -0.2567 -0.2139 -0.2241 -0.2118 -0.1802 -0.1661 -0.1868 
313.2 -0.2545 -0.3182 -0.2754 -0.2856 -0.2733 -0.2418 -0.2276 -0.2484 
<χ>(anion) -0.1492 0.794355 0.08703 0.17656 0.0172 -0.24795 -0.50690 -0.3305 
<χ>(cation) -0.13596 0.266749 0.06963 0.19678 0.09557 -0.30615 -0.34548 -0.08415 
         
 
  
Dynamic light-scattering measurements were performed to obtain a size distribution of the 
aggregates. The concentration chosen was twice the cmc, this way we ensured the presence of 
aggregates. The correlation functions from dynamic light scattering were analyzed by the Contin 
method.  Polydispersity indices generated by this analytical method were less than 0.1, indicative 
of a reasonable degree of monodispersity of size. (Fig. 2) shows the size distribution obtained. It is 
a single peak which corresponds to an aggregate with a mean diameter of 2.24 nm. Aggregation 
number can be estimated from this value. Assuming that the aggregates have spherical shape, the 
aggregation numbers are obtained from the total surface area of the aggregates and the minimum 
area per molecule 1.73 nm
2
 (obtained from surface tension measurements [143]). Thus, we obtain 
a mean value of 8 imipramine molecules per aggregate. This value correlates well with that 
obtained from static light scattering, 7 [134].  
5.1.5. The MIANN Models of Multiple Self-Assembly Properties of Surfactants   
In this work we have tried to obtain for the first time a linear model able to predict the 
probability with which a compound (i-th) presents an experimental value of the property (j-th) 
higher than the average value of this property for this data set. The best model found using LDA 
was the following:  
 
𝑆𝑖(𝑍𝑖𝑗 > 0) = 3,91375 + 0,011557 · 𝑒
𝐶𝑠𝑎𝑙𝑡 
(𝑚𝑜𝑙·𝐿−1)
− 0,012303 · 𝑇(𝐾)𝑗 + 0,244894
·  5𝜒(𝑎𝑛𝑖𝑜𝑛)𝑖 − 0,047320 ·  
5𝜒(𝑐𝑎𝑡𝑖𝑜𝑛)𝑖 + 1,919078 ·  
5〈𝜒〉(𝑎𝑛𝑖𝑜𝑛𝑠𝑗)
+ 3,436077 ·  5〈𝜒〉(𝑐𝑎𝑡𝑖𝑜𝑛𝑠)𝑗 𝑛 = 1085 𝜒
2 = 221,2429 𝑝(𝜒2) < 0.01 
(22) 
 
In this equation, Sij(Zij > 0) is a real-valued score (output of the linear model) that can be used 
to discriminate between surfactants with high probability p(Zij > 0) of showing a high Zij > 0 and 
others with high probability p(Zij ≤ 0) of presenting a Zij ≤ 0. Considering that Zij is a 
standardization coefficient used to scale the values of the different properties to a single 
adimensional scale, we calculated this parameter as follows: Zij = (Yij - <Y>j)/SDj. Where, Yij is 
the value of the j-th property of the i-th surfactant; <Y>j is the average value of its property in the 
data set and SDj is the standard deviation. These parameters allowed us to classify the surfactants 
as “active” => C = 1 => Zij > 0 => Yij > <Y>j or “non-active” => C = -1 => Zij ≤ 0 => Yij ≤ <Y>j, 
that is, surfactants with a higher or lower-than-the-average value of the observed property j-th. The 
independent terms of the equation are: Csalt is the concentration of the salt in the solvent used;  is 
the average electronegativity of the surfactant for the anion or cation part; and <χ> are the average 
value of χ for those surfactants with Zij > 0. These terms were calculated using the MARCH-
INSIDE software. In addition, n is the number of cases used to train the model and χ2 is Chi-square 
statistics with a given p-lvel = p(χ2). (Table 1) shows the overall results obtained for this model in 
training and validation series. We used this linear model to predict the behavior of imipramine in 
other experimental conditions, different from those used in the previous experiments. In the 
bottom part of (Table 2) we found the values of Sij(Zij > 0) predicted with this model for 
imipramine NaCl at 0.1 mol·Kg
-1
.  
  
Table 2. Results of the LDA vs. MIANN Analysis for Multiple Properties of Surfactants  
MIANN model 
Train  
Statistic Parameter 
 Validation 
Cij Total Correct (%)   (%) Correct Total 
           
LDA 1 403 293 72.7  Sensitivity  73.7 98 133 
 0 682 492 72.1  Specificity  72.8 166 228 
PNN 6:6-1085-2-2:1 1 403 56 13.9  Sensitivity  15.0 20 133 
 0 682 681 99.9  Specificity  100.0 228 228 
MLP 6:6-8-1:1 1 403 340 84.4  Sensitivity  85.7 114 133 
(MLP1) 0 682 527 77.3  Specificity  77.2 176 228 
MLP 6:6-10-1:1 1 403 347 86.1  Sensitivity  83.5 111 133 
(MLP2) 0 682 529 77.6  Specificity  76.3 174 228 
RBF 6:6-1-1:1 1 403 272 67.5  Sensitivity  69.2 92 133 
 0 682 410 60.1  Specificity  62.3 142 228 
LNN 6:6-1:1 1 403 297 73.7  Sensitivity  75.2 100 133 
 0 682 452 66.3  Specificity  67.1 153 228 
           
 
Table 3. Results of the MIANN Analysis One Enantioselective Reactions Network 
MIANN Model 
profile 
|Diff-eeR(%)|  
≥ 100 
Training  Statistic 
Parameter 
 CV 
Total Correct %   % Correct Total 
           
MLP1 10:10-8-1:1 yes 2683 2498 93.1  Sensitivity  92.6 1260 1361 
 no 14721 13617 92.5  Specificity  93.1 6831 7341 
MLP1 10:10-11-1:1 yes 2683 2544 94.8  Sensitivity  93.8 1277 1361 
 no 14721 13800 93.7  Specificity  94.2 6918 7341 
MLP1 10:10-12-1:1 yes 2683 2546 94.9  Sensitivity  93.7 1275 1361 
 no 14721 13810 93.8  Specificity  94.3 6921 7341 
MLP2 10:10-7-6-
1:1 
yes 2683 2513 93.7  Sensitivity  93.5 1272 1361 
 no 14721 13695 93.0  Specificity  93.6 6874 7341 
MLP2 10:10-10-
11-1:1 
yes 2683 2508 93.5  Sensitivity  93.2 1268 1361 
 no 14721 13645 92.7  Specificity  93.3 6850 7341 
RBF 10:10-1-1:1 yes 2683 1796 66.9  Sensitivity  66.1 899 1361 
 no 14721 9846 66.9  Specificity  67.4 4949 7341 
MLP2 10:10-9-12-
1:1 
yes 2683 2531 94.3  Sensitivity  93.5 1272 1361 
 no 14721 13762 93.5  Specificity  93.9 6891 7341 
LNN 10:10-1:1 yes 2683 1879 70.0  Sensitivity  71.4 972 1361 
 no 14721 10461 71.1  Specificity  69.8 5121 7341 
           
 
Next, we carried out an ANN analysis of the data set used before in order to obtain MIANN 
models. As usual, we carried out AI experiments with different ANN topologies. (Table 4) shows 
the most interesting results found. As we can note, some MIANN models improve the results 
obtained by LDA. For instance, the MIANN model MLP1 with profile MLP 6:6-8-1:1 improves 
LDA in terms of Sensitivity both in Training and external Validation series. Sensitivity of LDA 
was ≈ 72% whereas this MIANN model presented a Sensitivity > 84% in both series. It means that 
MIANN is able to improve LDA by 10 percent points. However, this is considered at cost of 
complicating the linear model, transforming it into a non-linear ANN with H1 = 8 (hidden 
neurons). (Table 2) depicts the overall results found with different MIANN models as well. Last, 
(Fig. 12) depicts the topology of the MLP1 model and the AUROC values of some of the MIANN 
models trained here. Notably, both the MLP1 and MLP2 have an AUROC = 0.89. However, it is 
well-known that MLP2 needs a second hidden layer of neurons, 10 more neurons in the present 
case (profile MLP 6:6-10-1:1), which complicates the model to gain nothing in terms of 
Sensitivity or Specificity with respect to MLP1, see (Table 2).  
 
 
 
Fig. (11). Topology of the ANN MLP1and AUROC plots of MIANN models for surfactants.  
 
 
 
Fig. (12). AUROC analysis of the MIANN models obtained for the reaction network. 
  
6. MIANN MODELS IN ORGANIC CHEMISTRY  
6.1. MIANN Approach to QSRR Models of Reaction Networks  
6.1.1. Short Introductory Note to QSRR Models  
The asymmetric 1,2-addition of organometallic reagents to imines is a powerful tool to form 
carbon-carbon bonds. Thus, it is possible to introduce a new stereogenic center in organic 
molecules[144-153],providing ready access to enantiomerically enriched amines with a 
stereogenic center at the α-position, an important structural feature in many biologically active 
compounds. These optically active amines are also important compounds because of their broad 
range of applications such as chiral auxiliaries, resolving agents and building blocks for the 
synthesis of natural and unnatural compounds, and their pharmacological properties [154-158]. In 
this kind of reactions many variables, substrates, organo-lithium reagents, chiral ligands, products 
and variables of reaction condition are involved. Therefore, there is a huge field of possible 
reactions to investigate.  
 
Quantitative Structure-Reactivity Relationships (QSRR) studies, based on molecular 
descriptors of chemical structure, may play an important role in the prediction of biological 
activity or specific property of a reaction. For example, the authors of ref. [159] describe QSRR 
for kinetic chain-transfer constants for 90 agents on styrene polymerization at 60º C in which 
three- and five-parameter correlations were obtained with R
2
 of 0.725 and 0.818, respectively. 
Other scientists propose substructural fragments as a simple and safe way to encode molecular 
structures in a matrix containing the occurrence of fragments of a given type [160]. Satoh and 
coworkers investigated a dataset of 131 reactions focusing on the changes of electronic features on 
the oxygen atoms at the reaction sites by principal component analysis and self-organizing neural 
networks analyses [161]. On the other hand, Long and Niu developed Quantitative Structure-
Property Relationship (QSPR) for rate constants (k) of alkylnaphthalene reactions with chlorine, 
hydroxyl and nitrate radicals using partial least squares (PLS) regression [162]. Different scientis 
investigated the prediction of oxidoreductase-catalyzed reactions based on atomic properties of 
metabolites [163]. As above-mentioned, QSRR models may be used to predict effect of changes in 
reaction variables over enantioselectivity but we also need tools to describe the huge amount of 
information generated. This sort of problem may be investigated using reaction networks to 
regroup reactions with inverse results in which the enantioneric excess and configuration are 
changed from R to S.  
 
In a previous work [164] we have constructed a MLR-QSRR equation to investigate which 
variables influence more strongly the change on enantioselectivity. The most important variables 
were the differences between the initial and final reaction for: product partition coefficient (∆Pp), 
chiral ligands hardness (∆Hl), solvent dipolar moment (∆Ds), reaction time (∆tr), reaction 
temperature (∆Tr), addition temperature (∆Ta), average enantiomeric excess for reactions using the 
same procedure (∆Ae), substrate molar refractivity (∆Mi), and steric constant (∆So) and hardness of 
organolithium compounds (∆Po), respectively. Using these variables, the best model found was:  
 
∆𝑒𝑒(𝑅)% = −6.60 + 5.80 · ∆𝑃𝑝 − 4.63 · ∆𝐻𝑖 − 23.08 · ∆𝐷𝑠 + 44.18 · ∆𝑡𝑟 − 1.23 · ∆𝑇𝑟
− 0.18∆𝑇𝑎 + 0.24∆𝐴𝑒 + 1.90 · ∆𝑆0 − 8.22 · ∆𝑃0 − 0.24 · ∆𝑀𝑖   𝑛
= 17404   𝑅2 = 0.803   𝑅2 𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑 = 0.803   𝐹 = 7120.7   𝑝 < 0.00001 
(22) 
 
where, n is the number of cases (reaction pairs) used to train the model, R
2
 and R
2
 adjusted are the 
training and adjusted square regression coefficients, F is Fisher ratio, and p the level of error. All 
these reactions have been previously reported in the literature [165-177]. This model, with ten 
variables, predicts correctly 80.3% of variance of the data set with a standard error of 29.35%. 
Notably, the adjusted values of R
2
 and R
2
 are equal, which indicates that the model is not over-
fitted due to incorporating an elevated number of parameters.  
  
In order to achieve the enantiomeric excess and configuration of the product with a network 
approach where one node represents a reaction and the edges show reaction pairs with high 
propensity to R/S chirality inversion, we carried out the following steps. First, we calculated the 
observed and QSRR-predicted average-scores that numerically characterize the propensity of one 
reaction to yield R/S chirality inversion. These scores were labelled as Obs. Avg.∆ee(R)% and 
Pred.Avg.∆ee(R)%: 
 
𝑂𝑏𝑠. 𝐴𝑣𝑔. ∆𝑒𝑒(𝑅)%𝑣 =
1
228
∑ ∆𝑒𝑒(𝑅)%𝑜𝑏𝑠.(𝑣, 𝑤) =
1
228
∑ (𝑒𝑒(𝑅)%𝑜𝑏𝑠(𝑣) −
𝑤=228
𝑊=1
𝑤=228
𝑤=1
𝑒𝑒(𝑅)%𝑜𝑏𝑠(𝑤))  
(23) 
  
Pr  𝑒𝑑. 𝐴𝑣𝑔. ∆𝑒𝑒(𝑅)%𝑣 =
1
228
∑ ∆𝑒𝑒(𝑅)%𝑝𝑟𝑒𝑑.(𝑣, 𝑤) =
1
228
∑ (𝑒𝑒(𝑅)%𝑝𝑟𝑒𝑑(𝑣) −
𝑤=228
𝑊=1
𝑤=228
𝑤=1
𝑒𝑒(𝑅)%𝑝𝑟𝑒𝑑(𝑤))  
(24) 
 
Where, Obs.Avg.∆ee(R)%v is the difference between observed R enantiomeric excess for 
reaction v minus observed R enantiomeric excess for reaction w and Pred.Avg. ∆ee(R)% is the 
difference between predicted R enantiomeric excess for reaction v minus observed R enantiomeric 
excess for reaction w. Then, we used these scores as inputs in a Microsoft-Excel sheet to calculate 
the elements of the Boolean or Adjacency matrix (A) associated to the reaction network as 
follows:  
 
𝐴 = {
𝑖𝑓 𝑠𝑖𝑔𝑛(𝑒𝑒(𝑅)%𝑜𝑏𝑠(𝑣)) = 𝑠𝑖𝑔𝑛(𝑒𝑒(𝑅)%𝑜𝑏𝑠(𝑤) ) 𝑡ℎ𝑒𝑛 𝛼𝑣𝑤 = 0
𝑒𝑙𝑠𝑒   
𝑖𝑓 [𝑂𝑏𝑠 𝐴𝑣𝑔 ∆𝑒𝑒(𝑅)%𝑣 − 𝑂𝑏𝑠 𝐴𝑣𝑔 ∆𝑒𝑒(𝑅)%𝑣] ≤ 𝑐𝑢𝑡 − 𝑜𝑓𝑓 𝑡ℎ𝑒𝑛 𝛼𝑣𝑤 = 0
𝑒𝑙𝑠𝑒  𝛼𝑣𝑤 = 1
  (25) 
 
In order to validate the model we used it to predict 26,106 reactions pairs never used to train 
the model (validation series). In this series the results were: R
2
 = 79.98%, F = 1043·10
2
 and p < 
0.00001. The model explains correctly 80.0% of variance of the data set with a standard error of 
29.79% in the validation series. These results indicate that we developed an accurate model 
according to previous reports on the use of MLR in QSRR [178-180]. In this previous work, we 
constructed the observed reaction using the observed values, considering the experimental data. 
Next, we predicted the reaction network with the QSRR model and last we compared both 
networks. In order to compare them, we used the sensitivity, specificity and accuracy by means of 
a Chi-Square test. The value obtained for the p < 0.00001 was with Chi-square = 293.364, 
demonstrating that both networks are very similar.  
6.1.2. MIANN-QSRR Model of Reaction Networks for 1,2-Addition of Organometallic Reagents to 
Imines  
We propose herein, for the first time, a MIANN-QSRR model able to predict the difference in 
enantiomeric excess for R-product between two pairs of reactions (∆ee(R)%) in the reaction 
network, which reaches similar/dissimilar enatioselectivity after the modification of reaction 
variables. These QSRR models combine the MI and ANN software to predict the configuration of 
the new stereogenic center formed in the synthesis of amines, taking into consideration similar 
reaction pairs in which the enantiomeric excess increases or reduces.  
6.1.3. MI Methods Used  
The MIANN model used here is based on the calculation of the different physicochemical 
molecular properties (λm) for substrates, organolithium reagents, chiral ligands and products (λs, 
λo, λl, λp), respectively. These λm are calculated as an average of atomic properties (λj). For 
instance, it is possible to derive average estimations of refractivities (MRs, MRo, MRl, MRp), 
partition coefficients (Ps, Po, Pl, Pp), and hardness (ηs, ηo, ηl, ηp) that we are going to use in this 
work, as seen in the equation below [85]:  
  
𝜆𝑚 =
1
6
∑  𝑘𝜆 =
1
6
∑  ∑𝑝𝑘(𝜆𝑗) · 𝜆𝑗
𝑗
5
𝑘=0
5
𝑘=0
 (26) 
 
It is possible to consider isolated atoms (k = 0) in the estimation of the molecular properties 0η, 
0χ, 0MR, 0α, 0P. In this case the probabilities 0p(λj) are determined without considering the 
formation of chemical bonds (simple additive scheme). However, it is also possible to consider the 
gradual effects of the neighboring atoms at different distances in the molecular backbone. In order 
to reach this goal, the method uses an MM, which determines the absolute probabilities 
k
p(λj) with 
which the atoms placed at different distances k affect the contribution of the atom j to the 
molecular property in question.  
 
𝑘𝜆 = [ 0𝑝(𝜆1)
0 𝑝(𝜆2)…  
0𝑝(𝜆𝑛)]
[
 
 
 
 
 1𝑝1,2  
1𝑝1,2  
1𝑝1,3 ·  
1𝑝1,𝑛
 1𝑝2,1  
1𝑝2,2  
1𝑝2,3 ·  
1𝑝2,𝑛
· · · · ·
· · · · ·
 1𝑝𝑛,1 · · ·  
1𝑝𝑛,𝑛]
 
 
 
 
𝑘
·
[
 
 
 
 
𝜆1
𝜆2
·
·
𝜆𝑛]
 
 
 
 
= ∑ 𝑘𝑝(𝜆𝑗) · 𝜆𝑗
𝑛
𝑗=1
 (27) 
 
Where, from left to right, the first term is 
kλ, which is the average molecular property 
considering the effects of all the atoms placed at distance k over every atomic property λj. The 
vector on the left side of the equation contains the probabilities 
0
p(λj) for every atom in the 
molecule, without considering chemical bonds. The matrix in the center of the equation is the so-
called stochastic matrix. The values of this matrix (
1
pij) are the probabilities with which every atom 
affects the parameters of the atom bonded to it. Both kinds of probabilities 
0
p(λj) and 
1
pij are easily 
calculated from atomic parameters (λj) and the chemical bonding information:  
 
 0𝑝𝑖𝑗 =
𝜆𝑗
∑ 𝜆𝑘
𝑛
𝑘=1
 (28) 
  
 1𝑝𝑖𝑗 =
𝛿𝑖𝑗 · 𝜆𝑗
∑ 𝛿𝑖𝑘 · 𝜆𝑘
𝑛
𝑘=1
 (29) 
 
The only difference is that in the probabilities 
0
p(λj) we consider isolated atoms by carrying out 
the sum in the denominator over all n atoms in the molecule. On the other hand, for 
1
pij chemical 
bonding is taken into consideration by means of the factor δij. This factor has the value 1 if atoms i 
and j are chemically bonded and it is 0 otherwise. All calculations were performed using the 
MARCH-INSIDE program version 3.0 [181], which can be obtained for free academic use, upon 
request, from the corresponding author of the present work.  
6.1.4. ANN Analysis  
Given the λm of the above-mentioned molecular parameters and λorv of the other reaction 
variables such as (T(a), T(r), t(r)), we can calculate the differences ∆λ = λ= (r2) - λ(r1) for any 
reaction pairs. Using these ∆λm and ∆λorv values as input we performed different ANN anlyses to 
fit the QSRR model, including the LNN equation with the form:  
 
Δ𝑒𝑒(𝑅)%𝑝𝑟𝑒𝑑 = ∑ 𝑏𝑚 · Δ𝜆𝑚 + ∑𝑏𝑜𝑟𝑣 · Δ𝜆𝑜𝑟𝑣 + 𝑏0
 
𝑜𝑟𝑣
 
𝑠,𝑙,𝑜,𝑝
 (30) 
 
The parameter ∆%ee (R)pred (the prediction of the difference in enantiomeric excess for R-
product between two pairs of reactions) is the output of the model. In equation (6), b represents the 
coefficients of the variables in the model, determined with the ANN module of the STATISTICA 
6.0 software package [99]. The data set included a series of reported an organolithuim addition to 
imines in presence of chiral ligands reactions.  
  
6.1.5. Results of the MIANN Model  
We studied the previous data set with different MIANN approaches: LNN, MLP1, MLP2, and 
RBF. (Table 3) shows the best results found. The LNN model gives good classification results 
with Sensitivity (Sn) and Specificity (Sp) higher than 70%, except for Sp in Cross-Validation (CV) 
series. These results of the MIANN analysis confirm the findings of our previous work. There is a 
strong linear relationship between the MI parameters studied and the inversion of chirality in the 
present reaction network, taking into consideration the change of specific reaction parameters as 
well. In any case, the use of non-linear MIANN strategy notably improved the results found with 
the linear MIANN model obtained by LNN. More specifically, the model 1 is a MIANN model 
with topology MLP1 that shows very high (>90%) values of Sn and Sp both in training and cv 
series, using only one hidden layer with 8 hidden neurons. (Fig. 12) shows the AUROC values of 
the MIANN model developed for the reaction network.  
CONCLUSIONS  
The MIANN models may be used to model very different data and reduce experimental costs 
in different areas of the molecular sciences, including Physical, Organic, and Medicinal 
Chemistry. In almost all cases the non-linear MIANN models improve the results obtained with a 
linear method.  
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